Blue Lake Biotechnology is developing intranasal vaccines that harness the full breadth of the immune system to keep people healthy, prevent serious infectious diseases, and protect the lives of vulnerable populations
Blue Lake is developing intranasal vaccines using a proprietary transformational parainfluenza virus 5 (PIV5)-based vector.
Our platform enables us to make robust yet well-tolerated vaccines that are easy to administer, easy to transport, and easy to manufacture.
